SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech informs about acquisition

12 Dec 2024 Evaluate
Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has informed that Concord biotech has made investment of USD 1,000,000 in Compulsorily convertible Notes of Palvella Therapeutics, Inc. In terms of the above referred provisions of the SEBI LODR Regulations, read with circular dated November 11, 2024 issued by the Securities and Exchange Board of India, bearing ref. no. SEBI/HO/CFD/PoD2/CIR/P/0155 (said SEBI Circular). The requisite details of terms of the provisions of Regulation 30 read with Schedule III of the SEBI LODR Regulations and the said SEBI circular, are included in Annexure A, as enclosed.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1046.80 -20.60 (-1.93%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×